성장을 멈추지 마세요

체험은 만족하셨나요?

현재 45,766명이 마이메르시로 공부 중이에요

지식 자료를 소장하고 멋진 의료인으로 성장하세요

학습 자료 둘러보기 →
Critical Medications & Drips in ICU | 마이메르시 MyMerci
제안하기

뭔가 하고 싶은 말이 있는거야?

0 / 2000
컨텐츠 수정하기

컨텐츠 내용을 수정할 수 있습니다

수정하기
닫기

Critical Medications & Drips in ICU

NCLEX Review Guide: Critical Care Medications & Drips in ICU

Vasoactive Medications

Vasopressors

  • Vasopressors are critical medications used to increase blood pressure through vasoconstriction and/or increased cardiac output. They are administered as continuous infusions through a central line due to their potential to cause tissue necrosis if extravasation occurs.
  • Titration is based on specific hemodynamic parameters including MAP (Mean Arterial Pressure), cardiac output, SVR (Systemic Vascular Resistance), and patient response.

Key Points

  • Always administer vasopressors through a central line
  • Continuous hemodynamic monitoring is essential during administration
  • Titrate to effect based on ordered parameters

Common Vasopressors Comparison

Medication Primary Receptor Primary Effect Clinical Use
Norepinephrine (Levophed) α1 > β1 Vasoconstriction First-line for septic shock
Epinephrine β1 = β2 = α1 ↑ HR, contractility, vasoconstriction Anaphylaxis, cardiac arrest
Dopamine Dose-dependent Low: renal, Med: cardiac, High: vasoconstriction Cardiogenic shock
Vasopressin V1 receptors Vasoconstriction Second-line for septic shock
Phenylephrine (Neo-Synephrine) α1 Pure vasoconstriction Neurogenic shock

Clinical Scenario:

A 68-year-old patient with septic shock has a MAP of 55 mmHg despite adequate fluid resuscitation. The provider orders norepinephrine at 0.05 mcg/kg/min, titrate to maintain MAP > 65 mmHg. After initiating the infusion, you would monitor for:

  • Improved blood pressure and tissue perfusion
  • Heart rate changes and potential dysrhythmias
  • Urine output as an indicator of renal perfusion
  • Peripheral circulation and signs of digital ischemia

IMPORTANT ALERT:

Never abruptly discontinue vasopressors. Always wean slowly to prevent rebound hypotension. If extravasation occurs, stop the infusion immediately and notify the provider for potential phentolamine administration to prevent tissue necrosis.

Norepinephrine (Levophed)

  • Norepinephrine is a potent alpha-adrenergic agonist with moderate beta-adrenergic effects, making it primarily a vasoconstrictor with some positive inotropic effects. It is the first-line vasopressor for septic shock due to its ability to increase systemic vascular resistance while preserving renal blood flow.
  • Typical dosing ranges from 0.01-3 mcg/kg/min, with careful titration based on MAP goals, typically 65 mmHg or higher as ordered.

Key Points

  • First-line agent for septic shock
  • Monitor for digital ischemia and decreased peripheral perfusion
  • Can cause reflex bradycardia due to increased blood pressure

Memory Aid:

"Noro-PINE" = Think of a pine tree standing tall and strong (increasing blood pressure) through vasoconstriction.

Epinephrine

  • Epinephrine acts on both alpha and beta receptors, increasing heart rate, contractility, and causing vasoconstriction. It is the drug of choice for anaphylaxis and cardiac arrest, and may be used as a second-line agent in septic shock.
  • Dosing typically ranges from 0.01-0.5 mcg/kg/min for shock states, with higher concentrations (1 mg) used during cardiac arrest resuscitation per ACLS protocols.

Key Points

  • Can cause significant tachycardia and increased myocardial oxygen demand
  • May increase lactate levels independent of tissue perfusion
  • Can cause hyperglycemia due to glycogenolysis

Vasopressin

  • Vasopressin (antidiuretic hormone) causes vasoconstriction through V1 receptors and is often used as an adjunct to catecholamine vasopressors. It is particularly useful in septic shock as these patients often have relative vasopressin deficiency.
  • Fixed dosing at 0.04 units/min is typical, without titration, as an adjunct to other vasopressors.

Key Points

  • Not typically used as a first-line agent
  • Does not cause tachycardia like adrenergic agents
  • Can cause peripheral ischemia and hyponatremia

Inotropic Medications

Dobutamine

  • Dobutamine primarily stimulates beta-1 receptors in the heart, increasing cardiac contractility and stroke volume without significant vasoconstriction. It is the inotrope of choice for cardiogenic shock when increased cardiac output is needed without raising blood pressure significantly.
  • Typical dosing ranges from 2-20 mcg/kg/min, titrated to achieve desired cardiac output improvement.

Key Points

  • May cause hypotension due to peripheral vasodilation at higher doses
  • Can significantly increase myocardial oxygen demand
  • Monitor for tachyarrhythmias during administration

Memory Aid:

"DOBUTamine makes the heart DO BETTER" - focusing on its primary effect of improving cardiac contractility.

Milrinone

  • Milrinone is a phosphodiesterase inhibitor that increases cardiac contractility and causes vasodilation. It improves cardiac output without significantly increasing heart rate or myocardial oxygen consumption, making it useful in patients with heart failure who cannot tolerate increased heart rates.
  • Typically administered as a loading dose of 50 mcg/kg over 10 minutes, followed by continuous infusion of 0.375-0.75 mcg/kg/min, with dose reduction necessary in renal impairment.

Key Points

  • Has a longer half-life than dobutamine, making weaning more gradual
  • Can cause significant hypotension due to vasodilation
  • Requires dose adjustment in renal dysfunction

IMPORTANT ALERT:

Milrinone can cause profound hypotension, especially in hypovolemic patients. Ensure adequate volume status before initiation.

Antiarrhythmic Medications

Amiodarone

  • Amiodarone is a Class III antiarrhythmic that prolongs repolarization and the refractory period in cardiac cells. It is used for both atrial and ventricular arrhythmias and is one of the few antiarrhythmics that can be used safely in patients with structural heart disease.
  • For critical care, loading doses of 150 mg over 10 minutes followed by 1 mg/min for 6 hours, then 0.5 mg/min for 18 hours are common protocols, with subsequent transition to oral therapy if indicated.

Key Points

  • Can cause hypotension during rapid IV administration
  • Monitor for QT prolongation and bradycardia
  • Has multiple drug interactions due to CYP450 enzyme inhibition

Lidocaine

  • Lidocaine is a Class IB antiarrhythmic that decreases automaticity in ventricular cells by blocking sodium channels. It is primarily used for ventricular arrhythmias, especially in the setting of acute myocardial infarction or cardiac surgery.
  • Typical dosing includes a 1-1.5 mg/kg bolus followed by continuous infusion at 1-4 mg/min, with careful monitoring for CNS toxicity.

Key Points

  • Primarily effective for ventricular arrhythmias
  • Signs of toxicity include perioral numbness, confusion, seizures
  • Requires dose reduction in liver dysfunction and heart failure

Sedation and Analgesia

Propofol

  • Propofol is a short-acting sedative-hypnotic agent that works by enhancing GABA effects in the CNS. It is commonly used for sedation in mechanically ventilated patients due to its rapid onset and offset, allowing for quick neurological assessments when temporarily discontinued.
  • Typical dosing ranges from 5-80 mcg/kg/min, titrated to desired level of sedation using validated sedation scales like RASS or SAS.

Key Points

  • Can cause significant hypotension due to vasodilation
  • Contains lipid emulsion that provides 1.1 kcal/mL (monitor triglycerides)
  • Propofol infusion syndrome risk with high doses (>4 mg/kg/hr) for >48 hours

IMPORTANT ALERT:

Propofol infusion syndrome presents with metabolic acidosis, rhabdomyolysis, hyperkalemia, and cardiac dysfunction. Immediately discontinue propofol if suspected.

Dexmedetomidine (Precedex)

  • Dexmedetomidine is an alpha-2 adrenergic agonist that provides sedation, anxiolysis, and some analgesia without significant respiratory depression. It allows patients to be easily aroused for assessment while providing adequate sedation at baseline.
  • Typically started at 0.2-0.7 mcg/kg/hr without a loading dose in critically ill patients, then titrated to effect up to 1.4 mcg/kg/hr.

Key Points

  • Preserves respiratory drive, making it useful for non-intubated patients
  • Can cause bradycardia and hypotension
  • May reduce delirium compared to benzodiazepines

Fentanyl

  • Fentanyl is a potent synthetic opioid analgesic that provides pain relief and some sedative effects. It is preferred in hemodynamically unstable patients due to minimal cardiovascular effects compared to other opioids.
  • Typical continuous infusion dosing ranges from 25-200 mcg/hr (0.7-10 mcg/kg/hr), titrated to pain control using validated pain assessment tools.

Key Points

  • Can cause chest wall rigidity at high doses or with rapid administration
  • Accumulates with prolonged use, leading to delayed awakening
  • Monitor for respiratory depression, especially when combined with other sedatives

Commonly Confused Points

Vasopressors vs. Inotropes

Characteristic Vasopressors Inotropes
Primary Action Vasoconstriction Increase cardiac contractility
Effect on BP Significantly increases Variable or modest increase
Effect on CO Variable Increases
Primary Use Distributive shock (septic, anaphylactic) Cardiogenic shock, heart failure
Examples Norepinephrine, Phenylephrine, Vasopressin Dobutamine, Milrinone

Dopamine Dose-Dependent Effects

Dose (mcg/kg/min) Primary Receptor Effect Clinical Effect Clinical Use
1-5 (Low) Dopaminergic Renal and mesenteric vasodilation Historical use for "renal protection" (now discouraged)
5-10 (Medium) Beta-1 adrenergic Increased cardiac contractility and heart rate Cardiogenic shock
10-20 (High) Alpha-1 adrenergic Vasoconstriction Hypotension, shock

Sedatives in Critical Care

Characteristic Propofol Dexmedetomidine Midazolam
Onset/Offset Very rapid Relatively rapid Intermediate
Respiratory Depression Significant Minimal Significant
Hemodynamic Effects Hypotension, vasodilation Bradycardia, mild hypotension Moderate hypotension
Delirium Risk Moderate Low (may be protective) High
Ideal Use Short-term sedation, neurological assessments Light sedation, non-intubated patients Seizures, alcohol withdrawal

Study Tips for Critical Care Medications

Vasopressor Memory Aid - "NAVEL"

  • Norepinephrine - First-line for septic shock (α1 > β1)
  • Adrenergic drugs (Epinephrine) - For anaphylaxis, cardiac arrest (β1 = β2 = α1)
  • Vasopressin - Adjunct in septic shock (V1 receptors)
  • Epinephrine - Also for bronchospasm (β2 effect)
  • Levophed - Another name for norepinephrine

Receptor Effects Memory Aid

"Alpha UP, Beta OUT"

  • Alpha receptors → UP the blood pressure (vasoconstriction)
  • Beta-1 receptors → OUTput of the heart (contractility, heart rate)
  • Beta-2 receptors → OUTward expansion of airways (bronchodilation)

    Vasopressor Administration Protocol

  1. Verify order and dosing parameters (target MAP/BP)
  2. Ensure patient has central venous access
  3. Use smart pump with drug library and double-check calculations
  4. Start at lowest dose and titrate according to parameters
  5. Monitor vital signs at least every 15 minutes during titration
  6. Assess peripheral circulation and urine output hourly
  7. Document all titrations and patient responses
  8. Prepare a second vasopressor if maximum dose reached without desired effect
  9. When weaning, decrease by small increments while monitoring for stability

Common Pitfalls in Critical Care Medication Administration

  • Administering vasopressors through peripheral IV instead of central line
  • Failing to adequately fluid resuscitate before starting vasopressors
  • Titrating based on systolic BP alone rather than MAP
  • Weaning vasopressors too quickly, causing rebound hypotension
  • Not adjusting propofol calories in nutrition calculations
  • Overlooking drug interactions with critical drips

Quick Check: Critical Care Medications

  1. Which vasopressor is first-line for septic shock? (Norepinephrine)
  2. What is the fixed dose for vasopressin infusion? (0.04 units/min)
  3. Which inotrope causes the least tachycardia? (Milrinone)
  4. What serious complication is associated with prolonged high-dose propofol? (Propofol infusion syndrome)
  5. Which sedative preserves respiratory drive and can be used in non-intubated patients? (Dexmedetomidine)

Self-Assessment Checklist

  • I can identify the primary receptor effects of major vasopressors
  • I understand the difference between vasopressors and inotropes
  • I can list major side effects of critical care medications
  • I know appropriate monitoring parameters for patients on vasoactive drips
  • I understand proper titration principles for critical care medications
  • I can identify signs of propofol infusion syndrome
  • I know which medications require central line administration

Remember: Understanding critical care medications is essential for safe practice in the ICU. Focus on the mechanisms of action, indications, and potential complications. When you understand the "why" behind each medication, you'll be better prepared to anticipate patient needs and respond appropriately to changes in patient condition. You've got this!

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.